Rafael Aguiar de Sousa, José Alcides Almeida de Arruda, Giovanna Ribeiro Souto, Sandra Beatriz Chaves Tarquinio, Ricardo Alves Mesquita, Victor Zanetti Drumond, Beatriz Lages Diniz Pereira, Mathias Ponche Barbosa, Bruno Augusto Benevenuto de Andrade, Jefferson R Tenório, Marcela Ferreira Abrahão Ribeiro, Paulo Eduardo Alencar de Souza, Martinho Campolina Rebello Horta, Maria Cássia Ferreira de Aguiar
PVL exhibits marked clinicopathological heterogeneity and substantial malignant potential. Prospective documentation is essential for applying diagnostic criteria, improving comparability across studies, and guiding surveillance.
OBJECTIVE: To describe the clinicodemographic and histopathological features of proliferative verrucous leukoplakia (PVL) in a multicenter cohort and assess the availability of variables required for retrospective application of contemporary diagnostic criteria.
STUDY DESIGN: This retrospective multicenter study included 40 patients with PVL from four Brazilian referral centers. All cases met a clinicopathological case definition based on the World Health Organization description of PVL. Clinicodemographic, histopathological, and follow-up data were analyzed descriptively. Medical records were reviewed for documentation of variables required by diagnostic criteria.
RESULTS: Most patients were female (85%); median age was 70 years. The gingiva/alveolar mucosa/retromolar area and buccal mucosa were the most frequent sites (55% each). At least two lesions were documented in 90% of patients, including three or more lesions in 72.5%. Nonhomogeneous morphology was documented in 47.5%. During a median follow-up of 3.8 years, recurrence occurred in 75% and malignant transformation in 22.5%. Patients underwent a median of two biopsies, showing findings ranging from hyperkeratosis to invasive squamous cell carcinoma. All variables required for retrospective application were documented in 24 cases (60%); at least one required variable was undocumented in 16 (40%).
CONCLUSION: PVL exhibits marked clinicopathological heterogeneity and substantial malignant potential. Prospective documentation is essential for applying diagnostic criteria, improving comparability across studies, and guiding surveillance.